Dataset Information

Elderly Medication Adherence Intervention Using the My Interventional Drug-Eluting Stent Educational App: Multisite Randomized Feasibility Trial.

ABSTRACT: BACKGROUND:A lifesaving treatment for myocardial infarction is the placement of a stent in a closed or obstructed coronary artery. The largest modifiable risk factor after receiving a stent is medication adherence to Dual AntiPlatelet Therapy, a combination of P2Y12 inhibitors and aspirin. OBJECTIVE:This study aimed to determine the acceptability of a protocol and an intervention using the My Interventional Drug-Eluting Stent Educational App (MyIDEA) and to evaluate medication adherence using the proportion of days covered (PDC) and platelet activation tests in a multisite randomized controlled trial. METHODS:Potential participants who received a post percutaneous coronary intervention (PCI) procedure with a drug-eluting stent were approached. All patients older than 50 years and who spoke English were recruited. Participants were recruited, baseline demographics were collected, and the Hospital Anxiety and Depression Scale (HADS), Rapid Estimate of Adult Literacy in Medicine-Short Form, Burden-Benefit questionnaire, 36-Item Short Form Health Survey, and PCI knowledge questionnaire were administered. Block randomization was used to randomize participants to either usual care or MyIDEA supplementation. MyIDEA is a personalized educational intervention based on the Kolb experiential learning theory using patient narratives for education. During the visits, participants' blood was collected to measure platelet suppression from medication. During the second and third encounters, the Morisky medication adherence score and cardiology outcomes were measured. The study was conducted at the University of Illinois Hospital and John H Stroger Jr Cook County Hospital with appropriate ethical approvals. Platelet suppression was measured through aspirin reactive units and P2Y12 reactive units. Medication adherence was measured using the PDC. The analysis team was blinded to the participants' group membership. The primary outcome was a feasibility analysis of recruitment and retention. RESULTS:The mean age of participants was 60.4 years (SD 7.1); the majority of patients were black and non-Hispanic. The majority of patients' reading levels were seventh grade or above, and they were not very familiar with other electronic devices for information and communication. The number of control subjects was 21, and the number of participants in the interventional arm was 24. The interventional group was able to use MyIDEA in both the hospital and outpatient setting. However, there was no significant difference in platelet suppression or medication adherence between groups. There were also differences between the groups in terms of depression and anxiety, initially, as measured by HADS. No documented adverse event associated with the intervention was found. CONCLUSIONS:Elderly patients are willing to use tablet devices to be educated about health conditions. Additional studies are required to measure the effectiveness and determine the most suitable timing and location for patient education. TRIAL REGISTRATION:ClinicalTrials.gov NCT04439864; https://clinicaltrials.gov/ct2/show/NCT04439864.

SUBMITTER: Boyd AD

PROVIDER: S-EPMC7381043 | biostudies-literature | 2020 Jun

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

Elderly Medication Adherence Intervention Using the My Interventional Drug-Eluting Stent Educational App: Multisite Randomized Feasibility Trial.

Boyd Andrew Dallas AD Ndukwe Chioma Iheanyi CI Dileep Anandu A Everin Olivia Frances OF Yao Yingwei Y Welland Betty B Field Jerry J Baumann Matt M Flores Jose D JD Shroff Adhir A Groo Vicki V Dickens Carolyn C Doukky Rami R Francis Regeena R Peacock Geraldine G Wilkie Diana J DJ

JMIR mHealth and uHealth 20200624 6

<h4>Background</h4>A lifesaving treatment for myocardial infarction is the placement of a stent in a closed or obstructed coronary artery. The largest modifiable risk factor after receiving a stent is medication adherence to Dual AntiPlatelet Therapy, a combination of P2Y12 inhibitors and aspirin.<h4>Objective</h4>This study aimed to determine the acceptability of a protocol and an intervention using the My Interventional Drug-Eluting Stent Educational App (MyIDEA) and to evaluate medication adh ...[more]

PMID: 32579120

Similar Datasets

Project description:BackgroundNonadherence produces considerable health consequences and economic burden to patients and payers. One approach to improve medication nonadherence that has gained interest in recent years is the use of smartphone adherence apps. The development of smartphone adherence apps has increased rapidly since 2012; however, literature evaluating the clinical app and effectiveness of smartphone adherence apps to improve medication adherence is generally lacking.ObjectiveThe aims of this study were to (1) provide an updated evaluation and comparison of medication adherence apps in the marketplace by assessing the features, functionality, and health literacy (HL) of the highest-ranking adherence apps and (2) indirectly measure the validity of our rating methodology by determining the relationship between our app evaluations and Web-based consumer ratings.MethodsTwo independent reviewers assessed the features and functionality using a 4-domain rating tool of all adherence apps identified based on developer claims. The same reviewers downloaded and tested the 100 highest-ranking apps including an additional domain for assessment of HL. Pearson product correlations were estimated between the consumer ratings and our domain and total scores.ResultsA total of 824 adherence apps were identified; of these, 645 unique apps were evaluated after applying exclusion criteria. The median initial score based on descriptions was 14 (max of 68; range 0-60). As a result, 100 of the highest-scoring unique apps underwent user testing. The median overall user-tested score was 31.5 (max of 73; range 0-60). The majority of the user tested the adherence apps that underwent user testing reported a consumer rating score in their respective online marketplace. The mean consumer rating was 3.93 (SD 0.84). The total user-tested score was positively correlated with consumer ratings (r=.1969, P=.04).ConclusionsMore adherence apps are available in the Web-based marketplace, and the quality of these apps varies considerably. Consumer ratings are positively but weakly correlated with user-testing scores suggesting that our rating tool has some validity but that consumers and clinicians may assess adherence app quality differently.

Project description:BackgroundResearch on adherence interventions in rheumatology is limited by methodological issues, particularly heterogeneous outcomes. We aimed to describe researchers' experiences with conducting interventional studies targeting medication adherence in rheumatology and their perspectives on establishing core outcomes.MethodsSemi-structured interviews using audio conference were conducted with researchers who had conducted an adherence study of any design in the past 10 years. Data collection and thematic analysis were performed iteratively, until saturation.ResultsWe interviewed 13 researchers, most of whom worked in academia and specialized in epidemiology and/or health services research. We identified three themes: 1) improving measurement of adherence (considering all phases of adherence, using appropriate and relevant measures, and establishing clinically meaningful thresholds); 2) challenges in designing and appraising adherence intervention studies (considering the confusion over a plethora of outcomes, difficulties with powering studies to demonstrate meaningful changes, and suboptimal descriptions of adherence interventions in published studies); and 3) advancing outcome assessment in adherence intervention studies (capturing rationale for developing a core domain set as well as recommendations and anticipated challenges by participants).ConclusionsUniquely gathering perspectives from international adherence researchers, our findings led to researcher-informed recommendations for improving adherence research including specifying the targeted adherence phase in designing interventions and studies and providing a glossary of terms to promote consistency in reporting. We also identified recommendations for developing a core domain set for interventional studies targeting medication adherence including involvement of patients, clinicians, and other stakeholders and methodological and practical considerations to establish rigor and support uptake.

Project description:BackgroundThe ability to jump has been related to muscle strength and power, speed and amplitude of the lower limbs movements, and specifically for the elderly, the vertical jump has been shown to be a good predictor of functional capacity and risk of falling. The use of a mobile application (App) which can measure the vertical jump (i.e., iPhone App My Jump) has recently emerged as a simple, cheap and very practical tool for evaluation of jump ability. However, the validity of this tool for the elderly population has not been tested yet. The elderly usually perform very low jumps and therefore the signal-to-noise ratio may compromise the validity and reliability of this method. Thus, the aim of the current study was to verify the validity and reliability of the iPhone App "My Jump" for the evaluation of countermovement jump (CMJ) height within an elderly population.MethodsAfter familiarization, 41 participants performed three CMJs assessed via a contact mat and the My Jump App. The intraclass correlation coefficient (ICC) was used to verify the relative reliability, while the coefficient of variation (CV%) and the typical error of measurement (TEM) were used to verify the absolute reliability. Pearson's correlation coefficient was used to verify the strength of the relationship between methods (i.e., concurrent validity), a Bland-Altman plot to show their agreement, and the Student's t-test to identify systematic bias between them. For reliability analyses, all jumps were considered (i.e., 123). All jumps (i.e., 123), the average height of each attempt (i.e., 41), and the highest jump, were considered for validity analyses.ResultsThe CMJ height of the highest jump was 10.78 ± 5.23 cm with contact mat, and 10.87 ± 5.32 with My Jump App, with an identified systematic bias of 0.096 cm (P = 0.007). There was a nearly perfect correlation between methods (r = 0.999; P = 0.000, in all cases) with a very good agreement observed (0.3255 to -0.5177 cm, 0.2797 to -0.5594 cm, and 0.3466 to -0.6264 cm, for highest jump height, average jump height, and all jump heights, respectively). The ICC of the My Jump App was 0.948, the TEM was 1.150 cm, and the CV was 10.10%.ConclusionOur results suggest that the My Jump App is a valid and reliable tool compared to the contact mat for evaluating vertical jump performance in the elderly. Therefore, it allows a simple and practical assessment of lower limbs' power in this population. For the elderly, as well as for other populations with low jumping heights, the highest jump height and the average jump height could be used indistinctly.

Dataset Information

Elderly Medication Adherence Intervention Using the My Interventional Drug-Eluting Stent Educational App: Multisite Randomized Feasibility Trial.

Publications

Elderly Medication Adherence Intervention Using the My Interventional Drug-Eluting Stent Educational App: Multisite Randomized Feasibility Trial.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets